Antimicrobial resistance has become a serious public health concern because of increased health care costs and significant morbidity and mortality.
THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM MERCK SHARP & DOHME CORP.
At the completion of this activity, the participant will be able to:
• Explore the threat of global antimicrobial resistance and its impact on health systems and patient outcomes
• Differentiate between newly approved treatment options for carbapenem-resistant Enterobacterales pathogens
• Examine targeted strategies for an effective antimicrobial stewardship program within an institution
Liza Vaezi, MSc, PharmD, BCPS-AQID, BCIDP
Infectious Diseases and Critical Care Pharmacist
Antimicrobial Stewardship Program, Co-Director, Virginia Mason Medical Center
Clinical Associate Professor, University of Washington Affiliation, Seattle, Washington
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: July 17, 2020
EXPIRATION DATE: July 17, 2021
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.